Why Would a Blood Pressure Reading Be Higher in One Arm
Hypertension guidelines recommend that blood pressure (BP) should exist assessed in both arms at the initial visit and the arm with the higher BP be used for BP cess at subsequent visits.one Several studies have pointed out that BPs differ between arms, with the right arm consistently reading higher past a small amount.2–eleven The only study that examined the reproducibility of interarm differences concluded that the differences betwixt arms were considering of random variation and were consistent only when obstructive arterial disease was present.11 However, the latter written report included simply 2 patients with obstructive arterial disease.
People who take chronic kidney affliction and those who are older are more likely to take obstructive arterial disease. Patients who have obstructive arterial affliction are more likely to have greater reproducibility of between-arm BP differences. However, this notion of greater reproducibility of BP differences has never been examined in such a population. Furthermore, there are no information to support whether the simple measurement of BP divergence between arms is of prognostic importance.
The objective of our study was to ascertain the reproducibility of BP differences between arms in a population known to accept greater prevalence of obstructive arterial affliction. Another aim was to assess the prognostic significance of the BP differences betwixt arms.
Methods
Study Cohort
This was a prospective cohort study. Sequent patients (n=423) were recruited from the renal clinic and a general medicine clinic of the Richard Fifty. Roudebush Veterans' Affairs (VA) Medical Center. Patients were excluded for body mass index >40 kg/thou2, acute renal failure, receiving renal replacement therapy, atrial fibrillation, or modify in their antihypertensive drugs within ii weeks of study enrollment. Chronic kidney disease (CKD) was defined as the presence of proteinuria on a spot urine specimen when the poly peptide/creatinine ratio was ≥0.22 one thousand/g or the estimated glomerular filtration charge per unit was <threescore mL/min per one.73 thou2 by the 4-component Modification of Diet in Renal Disease formula: 186×creatinine−0.154×age−0.203×0.74 if female person and×1.21 if black.12 Serum creatinine was non calibrated to Cleveland Clinic. Urine poly peptide/creatinine ratio of >0.22 g/g correlates with urine protein excretion of >300 mg/d, the standard definition of clinical proteinuria.thirteen Appropriately, nosotros selected this threshold of urine protein/creatinine ratio to reflect CKD.
The institutional review board of Indiana Academy and the research and evolution committee of the Richard L. Roudebush VA Medical Centre canonical this report, and all of the patients gave their written, informed consent.
BP Measurements
All of the measurements were recorded using the Sixth Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Claret Force per unit area guidelines by one nurse trained in the technique of BP measurement, using an appropriate gage size with an oscillometric monitor with a manual inflator (Model HEM 412C, Omron Healthcare). Patients were seated for ≥v minutes before measurements and refrained from smoking or caffeine ingestion for ≥xxx minutes. The patient'due south arm was kept at heart level during the measurement, and using an appropriate-sized cuff, 3 measurements were fabricated. BP in each arm was measured in triplicate in no prespecified order but in a sequential style. Measurements were repeated in both arms in triplicate at another clinic visit later one week. At least 30 seconds elapsed between BP measurements.
When whatsoever systolic BP differed past >25 mm Hg from the lowest recording in a consecutive gear up of 3 recordings in an arm or any diastolic BP differed from the lowest diastolic BP past >20 mm Hg, the recording was removed.11 Using these prespecified criteria, 185 recordings from 116 patients were removed. Of these, 99 systolic BP recordings were removed in 67 patients, and 97 diastolic BP recordings were removed from 71 patients.
Ascertainment of Mortality
The ascertainment of death was established using the computerized VA electronic medical chart system. The last date of visit to whatever VA facility was used to determine the last date of follow-upward. In patients who were non seen at a VA facility in the previous half-dozen months, the Social Security Death Index was checked for mortality. Finally, the Renal Network, which keeps authentic records of all dialysis patients in the region, was contacted to assess vital condition in those patients who were on dialysis but had not been seen recently (within six months) within the VA system.
Statistical Analysis
A linear mixed model with maximal likelihood interpretation was used to analyze the data.14 These analyses take into account the correlated nature of the observations and missing information. BP over visits was modeled using random coefficients, with each subject having random intercepts and slopes over visits. An unstructured covariance matrix best described the data and was used. Arms were nested within subjects. The fixed effects tested were visits (baseline or 1 calendar week), arm (right or left), and CKD (present or absent), as well as all of the interactions. The arm × CKD interaction and iii-way interactions were not pregnant and were removed from the final model. Model fit was tested using the likelihood ratio test, and no deterioration in model fit was noted after removal of these two terms.
Reproducibility was analyzed using a four-level variance component model. Random intercepts were used for arms nested within visits, which, in turn, were nested within subjects. Thus BP measurements (level 1) would accept on the same value for a given arm (level 2) across visits (level 3) or subjects (level 4) but would take on a unique value for a given combination of subject area, visit, and arm. The interaction among subject, visit, and arm tin can be interpreted as a subject- and visit-specific bias of the arms. Nosotros compared the successively nested models with ii levels (BP+subject), 3 levels (BP+subject+visit), and 4 levels (BP+bailiwick+visit+arm) using the likelihood ratio exam, and intraclass correlation coefficients were calculated (models A, B, and C, respectively, in Table 2).
Survival analyses were performed using the Cox model with the result of all-cause mortality. The baseline Cox model adjusted the absolute interarm difference at first visit with the average systolic BP at that visit (model A). Model B was further adjusted for CKD and model C for age. Proportionality assumption was tested by interacting the predictors with fourth dimension and testing the model fit of the nested model by the likelihood ratio exam and also past analyzing the Schoenfeld residuals.fifteen No bear witness for nonproportionality of hazards was establish. The functional form of the relationship between differences in BP between artillery and issue was analyzed using Martingale residuals.
All of the analyses were performed using Stata 10.0 (Stata Corp). P values were 2 sided and significance was set at 0.05.
Results
Betwixt Oct 2000 and June 2002, 421 sequent patients were recruited into the study and were followed upward until September 2007. The trial menstruum is shown in Effigy i. Of these, 203 patients (48%) had no kidney illness and 218 (52%) had CKD. Approximately 72% of the patients returned for a follow-upwardly visit at week ane. Baseline characteristics of the study sample are shown in Table ane. Equally expected, patients with CKD were older, had more than diabetes mellitus, greater systolic BP, lower resting heart charge per unit, greater antihypertensive drug use, more than vascular affliction, and in that location were less smokers.
- Download figure
- Download PowerPoint
Effigy 1. Patient disposition.
| Clinical Feature | Overall (n=421) | No CKD (due north=203) | CKD (north=218) |
|---|---|---|---|
| GFR indicates glomular filtration rate; ACE, angiotensin-converting enzyme. | |||
| Age, mean±SD, y | 62.nine±13.ii | 57.6±xiii.iii | 67.nine±eleven.0 |
| Men, n (%) | 401 (95) | 192 (95) | 209 (96) |
| Race, northward (%) | |||
| White | 311 (74) | 142 (70) | 169 (78) |
| Blackness | 107 (25) | 60 (29) | 47 (22) |
| Other | three (one) | 1 (ane) | 2 (ane) |
| Weight, mean±SD, kg | 95.3±25.4 | 96.1±28.ane | 94.7±25.five |
| Height, mean±SD, thousand | 1.76±0.08 | one.77±0.08 | 1.75±0.08 |
| Diabetes mellitus, n (%) | 146 (35) | 41 (20) | 105 (48) |
| Current smoker, n (%) | 115 (27) | 72 (36) | 43 (twenty) |
| Estimated GFR, mean±SD, mL/min per 1.73 thoutwo | 60.seven±29.viii | 86.1±16.8 | 38.0±18.4 |
| Spot urine protein/creatinine ratio, mean±SD, g/grand | 0.77±1.seven | 0.09±0.04 | one.25±2.07 |
| Albumin, mean±SD, g/dL | 3.8±0.iv | 3.8±0.iv | 3.8±0.4 |
| Hemoglobin, mean±SD, g/dL | 13.v±1.eight | 14.three±1.5 | 12.9±1.9 |
| Seated clinic BP, hateful±SD, mm Hg | 147.4±23.9/84.2±12.nine | 141.four±21.9/85.2±12.2 | 153.1±24.4/83.2±13.5 |
| Seated clinic eye rate, mean±SD, bpm | 71.8±xiii.0 | 74.1±12.9 | 69.7±12.8 |
| No. of antihypertensives drugs, mean±SD | ii.iii±one.six | 1.five±1.four | 2.ix±1.four |
| Nature of antihypertensive amanuensis | |||
| Thiazide diuretics, n (%) | 106 (25) | 56 (28) | 50 (23) |
| Loop diuretics, n (%) | 137 (33) | 21 (ten) | 116 (53) |
| Dihydropyridine calcium channel blockers, n (%) | 112 (27) | 27 (xiii) | 85 (39) |
| Nondihydropyridine calcium channel blockers, n (%) | 38 (ix) | 16 (8) | 22 (ten) |
| β-Blockers, n (%) | 164 (39) | 57 (28) | 107 (49) |
| α-Blockers, n (%) | 103 (24) | 34 (17) | 69 (32) |
| Centrally acting agents, due north (%) | 32 (8) | 8 (4) | 24 (11) |
| Vasodilators, northward (%) | 13 (3) | 2 (i) | 11 (5) |
| ACE inhibitors, n (%) | 193 (46) | 77 (38) | 116 (53) |
| Angiotensin receptor blockers, n (%) | 56 (13) | 14 (7) | 42 (19) |
| ACE inhibitors or angiotensin receptor blockers, n (%) | 236 (56) | 88 (43) | 148 (68) |
| Statin use, n (%) | 200 (48) | 65 (32) | 135 (62) |
| Aspirin employ, n (%) | 194 (46) | 76 (37) | 118 (54) |
| Myocardial infarction, n (%) | 98 (23) | 42 (21) | 56 (26) |
| Coronary artery bypass surgery, northward (%) | 51 (12) | 14 (seven) | 37 (17) |
| Percutaneous coronary revascularization, n (%) | 63 (fifteen) | 20 (10) | 43 (20) |
| Nitrate use, due north (%) | 88 (21) | 24 (12) | 64 (29) |
| Stroke, n (%) | 54 (13) | 19 (9) | 35 (16) |
| Peripheral vascular featherbed, n (%) | 22 (5) | two (ane) | 20 (ix) |
| Aortic aneurysm, n (%) | thirty (seven) | 2 (1) | 27 (12) |
Effigy 2 shows the box plots of systolic and diastolic BP betwixt arms, visits, and patients with and without CKD. The magnitude and direction of changes in BP are shown in Table ii. The right arm, on average, had 5.1-mm Hg higher systolic BP that attenuated by two.2 mm Hg over the next visit. Systolic BP was higher in CKD patients past eleven.half dozen mm Hg. Systolic BP dropped half-dozen.ix mm Hg from the first to 2nd visit and by an boosted 5.3 mm Hg if patients had CKD. Thus, the visit issue was much more marked in CKD patients. Similar results were noted for diastolic BP, except that a trend toward lower diastolic BP was seen in patients with CKD. Patients with college systolic BP had a autumn in BP and those with lower BP had an increment in BP from the first visit to the next. Thus, the intercepts and slopes of BP were inversely related. Regression to the mean was also observed for diastolic BP.
- Download figure
- Download PowerPoint
Effigy 2. Box plot of systolic BP among arms, visits, and presence and absence of CKD. The middle bar represents the median, and the box represents the 75th and 25th percentile. The upper whisker is the third quartile+1.v× interquartile range. The lower whisker is the get-go quartile−i.five×interquartile range. The estimates of differences amidst artillery, visits, and CKD are shown in Table 2.
| Parameter | Systolic BP | Diastolic BP | ||||
|---|---|---|---|---|---|---|
| Coefficient | 95% CI | P | Coefficient | 95% CI | P | |
| Arm×CKD and the 3-way interaction were non significant and were removed from the model. | ||||||
| Arm | −5.1 | −6.3 to −4.1 | <0.001 | −2.vi | −iii.3 to −1.ix | <0.001 |
| Visit | −6.9 | −nine.8 to −4.ane | <0.001 | −5.1 | −6.6 to −3.6 | <0.001 |
| CKD | 11.6 | 7.2 to sixteen.0 | <0.001 | −1.9 | −4.4 to 0.6 | 0.13 |
| Arm×visit | 2.2 | 0.7 to three.6 | <0.01 | 1.1 | 0.iii to 2.0 | 0.01 |
| Visit×CKD | −5.3 | −9.2 to −1.4 | <0.01 | −3.4 | −5.5 to −1.3 | <0.01 |
| Constant | 144 | 140.8 to 147.3 | <0.001 | 86.4 | 84.5 to 88.2 | <0.001 |
At baseline visit, 252 patients (61%) had between-arm systolic BP deviation inside 10 mm Hg, 118 (29%) had difference between 10 and 20 mm Hg, and 40 (ten%) had BP divergence that exceeded 20 mm Hg. At week 1 visit, 214 (72%) had systolic BP difference inside 10 mm Hg, 71 (24%) had difference betwixt x and xx mm Hg, and 12 (4%) had BP divergence that exceeded 20 mm Hg. Diastolic BP differences betwixt arms were inside 5 mm Hg in 237 patients (58%), within 5 to 10 mm Hg in 113 patients (28%), and exceeded 10 mm Hg in sixty patients (15%) at visit 1. The respective differences at the week 1 visit were 67%, 26%, and seven%, respectively. Table 3 shows the SDs between subjects, visits, and arms and the of the residuals in successive models. The residue SD cruel, and intraclass correlation coefficient improved with successive models accounting for the unique effects of visits and arms inside individuals.
| Random Parameter | Model A | Model B | Model C |
|---|---|---|---|
| SD is for systolic BP (mm Hg). Progressive model fits are better compared with the nested model (P<0.001). | |||
| Between-subject SD | 21.3 | 18.4 | 18.3 |
| Between-visit SD | thirteen.7 | 12.9 | |
| Between-arm SD | 7.two | ||
| Residuum SD | 12.five | 8.4 | half-dozen.4 |
| −Log likelihood | −17 188.ix | −xvi 115.two | −15 693.0 |
| Intraclass correlation coefficient | 0.74 | 0.88 | 0.93 |
The median duration of follow-up was 5.vi years. A total of 131 (31%) patients died over 2068 years of cumulative follow-up, yielding a crude mortality rate of 6.33 per 100 patient-years. Tabular array 4 shows the take chances ratio of increasing between-arm difference in systolic BP and all-cause mortality. For every 10-mm Hg increase in the divergence between arms, mortality increased 28%. CKD was a stiff run a risk factor for all-crusade mortality, and even after adjusting for CKD, the risk of betwixt-arm differences on mortality persisted. Effigy three shows the differences in bloodshed between patients with and without CKD. Nonetheless, increasing differences in systolic BP between arms were associated with increasing mortality regardless of the presence or absence of CKD. Historic period was correlated with CKD, BP, and between-arm BP differences. Although accounting for age removed the statistical significance of the betwixt-arm BP difference on mortality (Table iv, model C), the directionality of the observations was intact.
| Parameter | Take chances Ratios (95% CI) | ||
|---|---|---|---|
| Model A | Model B | Model C | |
| Progressive model fits are better compared with the nested model (P<0.001). | |||
| Between-arm difference in systolic BP (/x mm Hg) | 1.28 (1.04 to 1.57) | 1.24 (1.01 to 1.52) | ane.xviii (0.96 to ane.46) |
| Systolic BP (/x mm Hg) | 1.17 (1.09 to 1.26) | 1.12 (ane.04 to 1.21) | 1.07 (0.99 to 1.16) |
| CKD | iii.26 (ii.1 to 5.0) | 2.47 (one.59 to iii.82) | |
| Age (/y) | 1.05 (1.03 to one.07) | ||
| Log likelihood | −708.0 | −691.1 | −677.3 |
- Download figure
- Download PowerPoint
Figure 3. Cumulative hazards for decease. Cumulative hazards for expiry are plotted for patients with (top iii curves) and without CKD (bottom 3 curves). The iii curves from bottom to superlative in each category represent patients with no interarm systolic BP difference, fifteen-mm Hg difference, and 30-mm Hg divergence. All of the plots presume average systolic BP of 120 mm Hg at the baseline visit.
Discussion
In this study we constitute that in veterans attention a renal clinic or a general medicine clinic, in that location were consequent differences in BP between arms. At each of the visits, ≈30% of the patients had between-arm systolic BP differences that exceeded 10 mm Hg, and between 30% and 40% of the patients had between-arm diastolic BP differences that exceeded 5 mm Hg. On average, the right arm had ≈v-mm Hg higher systolic BP that attenuated by ≈2 mm Hg a week later. Systolic BP dropped ≈7 mm Hg from over ane week and by an boosted ≈v mm Hg in CKD patients. Accounting for the visit and arm event reduced the residual variance and improved the reproducibility of the measurements. Finally, every 10-mm Hg difference in systolic BP conferred a 24% higher mortality hazard after accounting for average systolic BP at baseline and CKD.
Interarm BP differences have been evaluated by several investigators.two–11 The magnitude of the differences betwixt arms has varied considerably between studies. For example, Singer and Hollander5 found systolic BP difference that exceeded 10 mm Hg in ≈xl% of the patients, similar to our report. In contrast, Eguchi et al11 noted that 23% of the patients had interarm systolic BP differences that exceeded 5 mm Hg in each of the 2 days, only the differences diminished every bit the number of BP readings increased. Other studies accept shown 10% to 20% prevalence of systolic BP interarm differences of ≥10 mm Hg.two–iv Sequential measurements reveal a slightly higher BP departure compared with the simultaneous method.11
We observed a significant regression of BP to the hateful in our patients. Those patients who had BP that was loftier initially had autumn in BP and vice versa. These effects were more pronounced in patients with CKD. Regression to the mean has been reported previously in patients with essential hypertension; however, patients with CKD appeared to have a greater regression to the mean.16 Although we did not specifically examine the mechanism of regression to the hateful in CKD patients, it is well recognized that patients with CKD have a heightened state of sympathetic activation.17 This activation may subside from one visit to the side by side and atomic number 82 to a greater fall in BP, as we observed in our sample.
The consistency of between-visit differences in BP has been evaluated by just 1 study.11 A meaning correlation in BP differences between arms from visit to visit was noted. Even so, on repeating the BP measurements at the same visit, the differences diminished and were no longer statistically significant. This led the authors to conclude that the differences between artillery were considering of random variation. In contrast to their written report, our patients had CKD, more diabetes, vascular disease, and were older. These characteristics may account for better reproducibility of BP differences between artillery in our study. Indeed, Eguchi et al11 reported 2 patients with vascular disease who had large interarm differences that were reproducible. Given that the differences in BP were of prognostic importance, we are led to believe that the differences betwixt arms in our sample were unlikely to exist considering of random variation.
At that place are some limitations of our report. Our population was predominantly men, given the make up of the United states veterans. Also, there was a high prevalence of vascular disease. Whether these results would hold in people with little vascular disease or who are young is non clear. Although we did not specify that the arm in which the BP is beginning measured be chosen at random, information technology is unlikely that the lack of randomization of artillery impaired the overall conclusion, because the lack of randomization would just add "noise" to the data.
Perspectives
Our information suggest that the right and left arm should not be used interchangeably to obtain BP recordings at repeated visits. Differences betwixt artillery are reproducible; therefore, the BP arm should be prespecified. In addition, the simple finding of BP difference betwixt arms confers a higher risk of mortality. Finally, our data testify a significant regression to the mean evident within 1 week, which has implications for clinical trials using clinic BP recordings. Thus, a second visit would probable provide more stable estimates of BP, peculiarly in patients with CKD. Larger studies in more diverse populations are needed to confirm the findings of our study.
Footnotes
References
- 1 Chobanian AV, Bakris GL, Blackness HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil South, Wright JT Jr, Roccella EJ. 7th report of the Articulation National Commission on Prevention, Detection, Evaluation, and Treatment of High Claret Pressure. Hypertension . 2003; 42: 1206–1252.LinkGoogle Scholar
- 2 Fotherby Doctor, Panayiotou B, Potter JF. Age-related differences in simultaneous interarm blood pressure level measurements. Postgrad Med J . 1993; 69: 194–196.CrossrefMedlineGoogle Scholar
- iii Lane D, Beevers One thousand, Barnes N, Bourne J, John A, Malins South, Beevers DG. Inter-arm differences in blood pressure: when are they clinically meaning? J Hypertens . 2002; 20: 1089–1095.CrossrefMedlineGoogle Scholar
- iv Arnett DK, Tang W, Province MA, Oberman A, Ellison RC, Morgan D, Eckfeldt JH, Hunt SC. Interarm differences in seated systolic and diastolic blood pressure: the Hypertension Genetic Epidemiology Network study. J Hypertens . 2005; 23: 1141–1147.CrossrefMedlineGoogle Scholar
- 5 Vocalist AJ, Hollander JE. Blood pressure. Assessment of interarm differences. Arch Intern Med . 1996; 156: 2005–2008.CrossrefMedlineGoogle Scholar
- vi Hashimoto F, Hunt WC, Hardy L. Differences between correct and left arm blood pressures in the elderly. West J Med . 1984; 141: 189–192.MedlineGoogle Scholar
- 7 Cassidy P, Jones Yard. A written report of inter-arm claret pressure differences in primary care. J Hum Hypertens . 2001; 15: 519–522.CrossrefMedlineGoogle Scholar
- 8 Orme S, Ralph SG, Birchall A, Lawson-Matthew P, McLean G, Channer KS. The normal range for inter-arm differences in claret pressure. Historic period Ageing . 1999; 28: 537–542.CrossrefMedlineGoogle Scholar
- ix Kimura A, Hashimoto J, Watabe D, Takahashi H, Ohkubo T, Kikuya M, Imai Y. Patient characteristics and factors associated with inter-arm difference of blood force per unit area measurements in a general population in Ohasama, Japan. J Hypertens . 2004; 22: 2277–2283.CrossrefMedlineGoogle Scholar
- ten Gould BA, Hornung RS, Kieso HA, Altman DG, Raftery EB. Is the blood pressure the same in both arms? Clin Cardiol . 1985; eight: 423–426.CrossrefMedlineGoogle Scholar
- 11 Eguchi K, Yacoub M, Jhalani J, Gerin West, Schwartz JE, Pickering TG. Consistency of blood pressure level differences between the left and correct arms. Curvation Intern Med . 2007; 167: 388–393.CrossrefMedlineGoogle Scholar
- 12 Manjunath Yard, Sarnak MJ, Levey AS. Prediction equations to judge glomerular filtration rate: an update. Curr Opin Nephrol Hypertens . 2001; x: 785–792.CrossrefMedlineGoogle Scholar
- xiii Wright JT Jr, Bakris One thousand, Greene T, Agodoa LY, Appel LJ, Charleston J, Cheek D, Douglas-Baltimore JG, Gassman J, Glassock R, Hebert L, Jamerson K, Lewis J, Phillips RA, Toto RD, Middleton JP, Rostand SG. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA . 2002; 288: 2421–2431.CrossrefMedlineGoogle Scholar
- xiv Rabe-Hesketh South, Skrondal A. Multilevel and Longitudinal Modeling Using Stata. Higher Station, TX: Stata Printing; 2005.Google Scholar
- 15 Cleves MA, Gould WW, Gutierrez RG. An Introduction to Survival Analysis Using Stata. Revised ed. College Station, TX: Stata Press; 2004.Google Scholar
- sixteen MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J. Blood force per unit area, stroke, and coronary heart disease. Function 1, Prolonged differences in blood force per unit area: prospective observational studies corrected for the regression dilution bias. Lancet . 1990; 335: 765–774.CrossrefMedlineGoogle Scholar
- 17 Converse RL Jr, Jacobsen TN, Toto RD, Jost CMT, Cosentino F, Fouad-Tarazi F, Victor RG. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med . 1992; 327: 1912–1918.CrossrefMedlineGoogle Scholar
Source: https://www.ahajournals.org/doi/10.1161/hypertensionaha.107.104943
Post a Comment for "Why Would a Blood Pressure Reading Be Higher in One Arm"